BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33482350)

  • 21. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
    Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of HIF-1α expression in patients with gastric cancer.
    Zhu CL; Huang Q; Liu CH; Lin XS; Xie F
    Mol Biol Rep; 2013 Nov; 40(11):6055-62. PubMed ID: 24057269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer.
    Lin S; Ma R; Zheng XY; Yu H; Liang X; Lin H; Cai XJ
    World J Gastroenterol; 2014 Jan; 20(4):1107-13. PubMed ID: 24574785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.
    Jin Y; Wang H; Ma X; Liang X; Liu X; Wang Y
    PLoS One; 2015; 10(5):e0127229. PubMed ID: 25993275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
    Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
    J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
    Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G;
    Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
    Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
    Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of HIF-1α in digestive system malignancies: evidence from a systematic review and meta-analysis.
    Arjmand MH; Moradi A; Rahimi HR; Es-Haghi A; Akbari A; Hadipanah MR; Afshar J; Mehrad-Majd H
    Gastroenterol Hepatol Bed Bench; 2022; 15(2):108-119. PubMed ID: 35845307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer.
    Cai FF; Xu C; Pan X; Cai L; Lin XY; Chen S; Biskup E
    Oncotarget; 2016 Nov; 7(47):77793-77806. PubMed ID: 27780920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: a meta-analysis.
    Ye LY; Zhang Q; Bai XL; Pankaj P; Hu QD; Liang TB
    Pancreatology; 2014; 14(5):391-7. PubMed ID: 25278309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer.
    Lin CS; Liu TC; Lee MT; Yang SF; Tsao TC
    Int J Med Sci; 2017; 14(8):785-790. PubMed ID: 28824314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients.
    Kaya AO; Gunel N; Benekli M; Akyurek N; Buyukberber S; Tatli H; Coskun U; Yildiz R; Yaman E; Ozturk B
    J BUON; 2012; 17(4):663-8. PubMed ID: 23335522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
    Camps C; Buffa FM; Colella S; Moore J; Sotiriou C; Sheldon H; Harris AL; Gleadle JM; Ragoussis J
    Clin Cancer Res; 2008 Mar; 14(5):1340-8. PubMed ID: 18316553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of HIFs expression in head and neck cancer: a systematic review.
    Gong L; Zhang W; Zhou J; Lu J; Xiong H; Shi X; Chen J
    PLoS One; 2013; 8(9):e75094. PubMed ID: 24058651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
    Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
    World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.
    Hung JJ; Yang MH; Hsu HS; Hsu WH; Liu JS; Wu KJ
    Thorax; 2009 Dec; 64(12):1082-9. PubMed ID: 19778933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma.
    Valencak J; Kittler H; Schmid K; Schreiber M; Raderer M; Gonzalez-Inchaurraga M; Birner P; Pehamberger H
    Clin Exp Dermatol; 2009 Dec; 34(8):e962-4. PubMed ID: 20055873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.
    Dales JP; Garcia S; Meunier-Carpentier S; Andrac-Meyer L; Haddad O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Cancer; 2005 Sep; 116(5):734-9. PubMed ID: 15849727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.